共 50 条
- [33] Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12): : 1107 - 1120
- [34] Lenalidomide active in patients with refractory or relapsed chronic lymphocytic leukemia Nature Clinical Practice Oncology, 2007, 4 (3): : 143 - 143